TCTC Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $393K | Buy |
3,112
+599
| +24% | +$78.9K | 0.01% | 190 |
|
|
2026
Q1 | $350K | Hold |
2,513
| – | – | 0.01% | 182 |
|
|
2025
Q4 | $308K | Hold |
2,513
| – | – | 0.01% | 188 |
|
|
2025
Q3 | $279K | Hold |
2,513
| – | – | 0.01% | 184 |
|
|
2025
Q2 | $279K | Hold |
2,513
| – | – | 0.01% | 186 |
|
|
2025
Q1 | $282K | Sell |
2,513
-251
| -9% | -$25.9K | 0.01% | 185 |
|
|
2024
Q4 | $255K | Buy |
2,764
+251
| +10% | +$22.6K | 0.01% | 190 |
|
|
2024
Q3 | $211K | Sell |
2,513
-1,380
| -35% | -$105K | 0.01% | 199 |
|
|
2024
Q2 | $267K | Sell |
3,893
-31
| -0.8% | -$2.07K | 0.01% | 182 |
|
|
2024
Q1 | $287K | Sell |
3,924
-260
| -6% | -$20K | 0.01% | 167 |
|
|
2023
Q4 | $339K | Hold |
4,184
| – | – | 0.01% | 158 |
|
|
2023
Q3 | $314K | Buy |
4,184
+31
| +0.7% | +$2.38K | 0.01% | 154 |
|
|
2023
Q2 | $320K | Hold |
4,153
| – | – | 0.01% | 157 |
|
|
2023
Q1 | $345K | Buy |
4,153
+353
| +9% | +$29.2K | 0.01% | 155 |
|
|
2022
Q4 | $326K | Buy |
3,800
+1,850
| +95% | +$147K | 0.01% | 152 |
|
|
2022
Q3 | $120K | Hold |
1,950
| – | – | 0.01% | 202 |
|
|
2022
Q2 | $121K | Hold |
1,950
| – | – | 0.01% | 208 |
|
|
2022
Q1 | $116K | Sell |
1,950
-130
| -6% | -$8.31K | ﹤0.01% | 227 |
|
|
2021
Q4 | $151K | Hold |
2,080
| – | – | 0.01% | 226 |
|
|
2021
Q3 | $145K | Buy |
2,080
+130
| +7% | +$9.13K | 0.01% | 208 |
|
|
2021
Q2 | $134K | Hold |
1,950
| – | – | 0.01% | 202 |
|
|
2021
Q1 | $126K | Hold |
1,950
| – | – | 0.01% | 203 |
|
|
2020
Q4 | $114K | Sell |
1,950
-890
| -31% | -$53.7K | 0.01% | 201 |
|
|
2020
Q3 | $179K | Buy |
2,840
+890
| +46% | +$61.7K | 0.01% | 165 |
|
|
2020
Q2 | $150K | Sell |
1,950
-2,203
| -53% | -$169K | 0.01% | 172 |
|
|
2020
Q1 | $310K | Hold |
4,153
| – | – | 0.02% | 127 |
|
|
2019
Q4 | $270K | Hold |
4,153
| – | – | 0.01% | 145 |
|
|
2019
Q3 | $263K | Buy |
4,153
+250
| +6% | +$16.3K | 0.01% | 144 |
|
|
2019
Q2 | $264K | Hold |
3,903
| – | – | 0.01% | 149 |
|
|
2019
Q1 | $254K | Hold |
3,903
| – | – | 0.01% | 151 |
|
|
2018
Q4 | $244K | Sell |
3,903
-380
| -9% | -$26.6K | 0.01% | 145 |
|
|
2018
Q3 | $331K | Hold |
4,283
| – | – | 0.02% | 139 |
|
|
2018
Q2 | $303K | Sell |
4,283
-500
| -10% | -$35.3K | 0.01% | 141 |
|
|
2018
Q1 | $361K | Hold |
4,783
| – | – | 0.02% | 128 |
|
|
2017
Q4 | $343K | Buy |
4,783
+500
| +12% | +$38K | 0.02% | 132 |
|
|
2017
Q3 | $347K | Hold |
4,283
| – | – | 0.02% | 131 |
|
|
2017
Q2 | $303K | Hold |
4,283
| – | – | 0.02% | 135 |
|
|
2017
Q1 | $291K | Sell |
4,283
-1,058
| -20% | -$74.4K | 0.02% | 156 |
|
|
2016
Q4 | $382K | Sell |
5,341
-210
| -4% | -$15.6K | 0.02% | 134 |
|
|
2016
Q3 | $439K | Hold |
5,551
| – | – | 0.03% | 119 |
|
|
2016
Q2 | $463K | Buy |
5,551
+210
| +4% | +$18.6K | 0.03% | 127 |
|
|
2016
Q1 | $491K | Hold |
5,341
| – | – | 0.03% | 127 |
|
|
2015
Q4 | $540K | Hold |
5,341
| – | – | 0.03% | 124 |
|
|
2015
Q3 | $524K | Buy |
5,341
+3,333
| +166% | +$370K | 0.03% | 122 |
|
|
2015
Q2 | $235K | Buy |
+2,008
| New | +$219K | 0.01% | 155 |
|
|
2014
Q4 | – | Sell |
-2,008
| Closed | -$214K | – | 174 |
|
|
2014
Q3 | $214K | Buy |
+2,008
| New | +$197K | 0.01% | 159 |
|
Other funds holding GILD
TCTC Holdings's GILD Position: Q2 2026 in Review
TCTC Holdings increased its Gilead Sciences (GILD) stake by 24% in Q2 2026, buying an estimated $78.9K and bringing the position to 3,112 shares worth $393K. The position accounts for 0.01% of the portfolio, ranked #190.
TCTC Holdings first reported a position in GILD in Q3 2014 and has held it in 46 quarters since. The position peaked at $540K in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- TCTC Holdings held 3,112 shares of Gilead Sciences worth $393K as of Q2 2026.
- TCTC Holdings bought 599 Gilead Sciences shares in Q2 2026, an estimated $78.9K.
- Gilead Sciences made up 0.01% of TCTC Holdings's portfolio in Q2 2026, its #190 holding.
- TCTC Holdings first reported a position in Gilead Sciences in Q3 2014 and has held it in 46 quarters since.
- TCTC Holdings's Gilead Sciences position peaked at $540K in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on TCTC Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.